These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 17511441)
21. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006. Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863 [TBL] [Abstract][Full Text] [Related]
22. IBC's Drug Discovery Technology - Europe 2001. 23-26 April 2001, Stuttgart, Germany. Kubinyi H IDrugs; 2001 Jul; 4(7):776-82. PubMed ID: 15995933 [TBL] [Abstract][Full Text] [Related]
23. Editorial opinion: chemoinformatics - a ten year update. Brown F Curr Opin Drug Discov Devel; 2005 May; 8(3):298-302. PubMed ID: 15892243 [TBL] [Abstract][Full Text] [Related]
24. Challenges for chemoinformatics education in drug discovery. Wild DJ; Wiggins GD Drug Discov Today; 2006 May; 11(9-10):436-9. PubMed ID: 16635806 [TBL] [Abstract][Full Text] [Related]
25. Hit finding: towards 'smarter' approaches. Langer T; Hoffmann R; Bryant S; Lesur B Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852 [TBL] [Abstract][Full Text] [Related]
26. The synergy between combinatorial chemistry and high-throughput screening. Diller DJ Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088 [TBL] [Abstract][Full Text] [Related]
29. Chemoinformatics: a view of the field and current trends in method development. Vogt M; Bajorath J Bioorg Med Chem; 2012 Sep; 20(18):5317-23. PubMed ID: 22483841 [TBL] [Abstract][Full Text] [Related]
30. Web service infrastructure for chemoinformatics. Dong X; Gilbert KE; Guha R; Heiland R; Kim J; Pierce ME; Fox GC; Wild DJ J Chem Inf Model; 2007; 47(4):1303-7. PubMed ID: 17602467 [TBL] [Abstract][Full Text] [Related]
31. The use of informatics and automation to remove bottlenecks in drug discovery. Calvert S; Stewart FP; Swarna K; Wiseman JS Curr Opin Drug Discov Devel; 1999 May; 2(3):234-8. PubMed ID: 19649951 [TBL] [Abstract][Full Text] [Related]
32. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Heilker R; Wolff M; Tautermann CS; Bieler M Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411 [TBL] [Abstract][Full Text] [Related]
33. A bio-medical informatics perspective on human factors. Findings from the Yearbook 2008 Section on Human Factors. Ruch P Yearb Med Inform; 2008; ():41-3. PubMed ID: 18660874 [TBL] [Abstract][Full Text] [Related]
35. Biodiversity informatics: organizing and linking information across the spectrum of life. Sarkar IN Brief Bioinform; 2007 Sep; 8(5):347-57. PubMed ID: 17704120 [TBL] [Abstract][Full Text] [Related]
36. Druggable targets and targeted drugs: enhancing the development of new therapeutics. Billingsley ML Pharmacology; 2008; 82(4):239-44. PubMed ID: 18802381 [TBL] [Abstract][Full Text] [Related]
37. Combinatorial biosynthesis for drug development. Menzella HG; Reeves CD Curr Opin Microbiol; 2007 Jun; 10(3):238-45. PubMed ID: 17553731 [TBL] [Abstract][Full Text] [Related]
38. Antisense oligonucleotides for target validation and gene function determination. Taylor MF IDrugs; 1999 Aug; 2(8):777-81. PubMed ID: 16127653 [TBL] [Abstract][Full Text] [Related]
39. Chemoinformatics: recent advances at the interfaces between computer and chemical information sciences, chemistry, and drug discovery. Bajorath J Bioorg Med Chem; 2012 Sep; 20(18):5316. PubMed ID: 22980097 [No Abstract] [Full Text] [Related]
40. Reflections on biomedical informatics: from cybernetics to genomic medicine and nanomedicine. Maojo V; Kulikowski CA Stud Health Technol Inform; 2006; 124():19-24. PubMed ID: 17108499 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]